{"Title": "OnabotulinumtoxinA in chronic migraine: predictors of response. A prospective multicentre descriptive study", "Year": 2018, "Source": "Eur. J. Neurol.", "Volume": "25", "Issue": 2, "Art.No": null, "PageStart": 411, "PageEnd": 416, "CitedBy": 32, "DOI": "10.1111/ene.13523", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85038232654&origin=inward", "Abstract": "\u00a9 2017 EANBackground and purpose: OnabotulinumtoxinA is a treatment specifically approved for the prophylaxis of chronic migraine in adults. The aim of this study was to assess the effectiveness of OnabotulinumtoxinA in chronic migraine after 1 year of treatment in a real-life setting and to identify clinical predictors of outcome. Methods: We designed a prospective multicentre study performed in 13 hospitals in Spain. Patients underwent a complete medical history and examination. They were treated with OnabotulinumtoxinA every 12 weeks for 1 year. Data about outcome, adverse events, abortive medication use, emergency room use and disability were collected at 3 and 12 months. Results: A total of 725 subjects completed the study. At 12 months, 79.3% showed >50% reduction in number of headaches per month and 94.9% reported no adverse events. Unilaterality of pain, fewer days of disability per month and milder headache at baseline were correlated with good outcome. Duration of disease <12 months increased the chances of response to treatment with OnabotulinumtoxinA (odds ratio, 1.470; 95% confidence interval, 1.123\u20132.174; P = 0.045). Conclusions: This study confirmed the effectiveness of treatment with OnabotulinumtoxinA after 1 year of treatment. The chances of a good outcome may be increased by starting treatment in the first 12 months after chronic migraine diagnosis.", "AuthorKeywords": ["chronic migraine", "early treatment", "effectiveness", "OnabotulinumtoxinA", "predictors"], "IndexKeywords": ["Adult", "Botulinum Toxins, Type A", "Chronic Disease", "Female", "Humans", "Male", "Middle Aged", "Migraine Disorders", "Neuromuscular Agents", "Outcome Assessment (Health Care)", "Prospective Studies"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 0, "EID": "2-s2.0-85038232654", "SubjectAreas": [["Neurology", "NEUR", "2808"], ["Neurology (clinical)", "MEDI", "2728"]], "AuthorData": {"57193400965": {"Name": "Dom\u00ednguez C.", "AuthorID": "57193400965", "AffiliationID": "60002983, 60028419", "AffiliationName": "Service of Neurology, Headache Unit, Hospital Cl\u00ednico Universitario, University of Santiago de Compostela"}, "7005680825": {"Name": "Leira R.", "AuthorID": "7005680825", "AffiliationID": "60002983, 60028419", "AffiliationName": "Service of Neurology, Headache Unit, Hospital Cl\u00ednico Universitario, University of Santiago de Compostela"}, "6506448221": {"Name": "Pozo-Rosich P.", "AuthorID": "6506448221", "AffiliationID": "60108505, 60012486, 60023020", "AffiliationName": "Hospital Universitario Vall d'Hebron, Headache Research Group, Vall d'Hebron Institute of Research (VHIR), Universitat Autonoma de Barcelona"}, "55884171400": {"Name": "Torres-Ferr\u00fas M.", "AuthorID": "55884171400", "AffiliationID": "60108505, 60012486, 60023020", "AffiliationName": "Hospital Universitario Vall d'Hebron, Headache Research Group, Vall d'Hebron Institute of Research (VHIR), Universitat Autonoma de Barcelona"}, "57199652023": {"Name": "Hern\u00e1ndez-Beltr\u00e1n N.", "AuthorID": "57199652023", "AffiliationID": "120109853", "AffiliationName": "Neuroclinica and Promedan"}, "6506889229": {"Name": "Jurado-Cobo C.", "AuthorID": "6506889229", "AffiliationID": "60031142", "AffiliationName": "Hospital Universitario Reina Sof\u00eda"}, "25723080000": {"Name": "Gonz\u00e1lez-Oria C.", "AuthorID": "25723080000", "AffiliationID": "60033267", "AffiliationName": "Hospital Universitario Virgen del Roc\u00edo"}, "7102756249": {"Name": "Santos S.", "AuthorID": "7102756249", "AffiliationID": "60033448", "AffiliationName": "Hospital Cl\u00ednico Universitario Lozano Blesa"}, "7003371150": {"Name": "Monz\u00f3n M.", "AuthorID": "7003371150", "AffiliationID": "106937166", "AffiliationName": "Hospital Royo Vilanova"}, "36628823800": {"Name": "Latorre G.", "AuthorID": "36628823800", "AffiliationID": "60021046", "AffiliationName": "Hospital Universitario de Fuenlabrada"}, "6701625178": {"Name": "\u00c1lvaro L.", "AuthorID": "6701625178", "AffiliationID": "60015927", "AffiliationName": "Hospital Universitario Basurto"}, "55248430200": {"Name": "Gago A.", "AuthorID": "55248430200", "AffiliationID": "60015927", "AffiliationName": "Hospital Universitario Basurto"}, "57191405912": {"Name": "Gallego M.", "AuthorID": "57191405912", "AffiliationID": "60024257", "AffiliationName": "Hospital Universitario La Princesa"}, "56241965400": {"Name": "Medrano V.", "AuthorID": "56241965400", "AffiliationID": "60002828", "AffiliationName": "Hospital General Universitario de Elda"}, "19337007000": {"Name": "Huerta M.", "AuthorID": "19337007000", "AffiliationID": "100616417", "AffiliationName": "Hospital Viladecans"}, "55581047400": {"Name": "Garc\u00eda-Alhama J.", "AuthorID": "55581047400", "AffiliationID": "60011805", "AffiliationName": "Hospital Universitario de Bellvitge"}, "6602570500": {"Name": "Belv\u00eds R.", "AuthorID": "6602570500", "AffiliationID": "60011805", "AffiliationName": "Hospital Universitario Dexeus"}, "56707470700": {"Name": "Leira Y.", "AuthorID": "56707470700", "AffiliationID": "112993065", "AffiliationName": "OMEQUI Research Group, Health Research Institute of Santiago de Compostela (IDIS)"}}}